The largest database of trusted experimental protocols

Milliplex map high sensitivity human cytokine magnetic bead panel

Manufactured by Merck Group
Sourced in United States

The Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead Panel is a multiplex assay designed to quantitatively measure multiple human cytokines in a single sample. The panel utilizes magnetic beads coated with specific antibodies to capture and detect the target analytes. This product provides a high-sensitivity solution for the simultaneous measurement of various cytokines in biological samples.

Automatically generated - may contain errors

6 protocols using milliplex map high sensitivity human cytokine magnetic bead panel

1

Biomarkers of Oxidative Stress and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Urine samples with sufficient remaining volume were also utilized for measurement of two biomarker of oxidative stress (N=1678 samples, N=482 subjects) including 8-isoprostane and 8-OHdG. Both were measured using enzyme immunoassay by Cayman Chemical Company (Ann Arbor, MI, USA). Inflammation biomarkers, including CRP as well as the cytokines IL-1β, IL-6, IL-10, and TNF-ɑ were measured in plasma from blood samples collected from participants at the same time as urine samples (N=1585 samples, N=482 subjects). CRP was measured using enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN, USA) and cytokines were measured using the Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead Panel (EMD Millipore Corp., St. Charles, MO, USA). Analyses were performed at the Cancer Center Immunology Core at the University of Michigan (Ann Arbor, MI, USA). All outcome biomarker levels reported below the LOD were kept as is and others were imputed as the LOD divided by the square root of 2.
+ Open protocol
+ Expand
2

Comprehensive Plasma Lipid and Cytokine Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A panel of 51 eicosanoids and lipid metabolites were measured in plasma samples using a 6490 Triple Quadrupole mass spectrometer (Agilent, New Castle, DE, USA). The individual eicosanoids were identified using metabolite-specific fragmentation and retention times12 . We used the Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead Panel (EMD Millipore Corp., St. Charles, MO) to measure four cytokines: IL-1β, IL-6, TNF-α, and IL-10. An additional inflammation marker, CRP, was also measured using a DuoSet enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN)10 (link).
We measured three protein oxidation markers in plasma samples: 3-nitrotyrosine [NY], 3-chlorotyrosine [CY], and o,o’-dityrosine [DY]. To quantify these biomarkers, total plasma protein was first precipitated and diluted with a phosphate buffer. The samples were then delipidated, injected with isotopically labeled standards, and hydrolyzed for 24 h. Subsequently, the processed plasma samples underwent liquid chromatography-electrospray ionization tandem mass spectrometry. Additional oxidative stress markers 8-IP and 8-OHdG were measured in urine samples at Cayman Chemical (Ann Arbor, MI). 8-IP was quantified using affinity column chromatography followed by an enzyme immunoassay, and 8-OHdG was measured directly through an enzyme immunoassay48 .
+ Open protocol
+ Expand
3

Quantifying Inflammatory Cytokines and Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytokines IL-1β, IL-6, IL-8, IL-10, and TNFα were quantified using the Milliplex MAP High Sensitivity Human Cytokine magnetic bead panel (EMD Millipore Corp., St. Charles, MO, USA) with plates read on a Luminex 200 system using xPonent software, version 3.1 (Luminex Corporation, Austin, TX, USA). 50 μL of plasma was analysed per well, and all samples were assayed in duplicate as per the manufacturer's recommendation. Normalisation of data from different assay plates was performed by Merck Millipore (Frenchs Forest, NSW, Australia). Data for IL-10 was subsequently excluded from analyses due to excessive variance from the reported sensitivity and performance of the IL-10 assay. To confirm the accuracy of the Luminex system, IL-6 results were compared with those obtained using a quantitative enzyme immunoassay (Quantikine HS; R&D Systems Inc., Minneapolis, MN) and found to be highly correlated (P < 0.0001). von Willebrand factor (vWF) activity was measured with the ATA-Liatest vWF kit (Diagnostica Stago, Parsippany, NJ) and Diagnostica Stago STAR-automated coagulation analyser. High sensitivity C-reactive protein (hsCRP) levels were determined with an immunonephelometric method (Dade Behring Marburg GmbH, Marburg, Germany).
+ Open protocol
+ Expand
4

Plasma Biomarkers Measurement Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma CRP was analyzed using a DuoSet enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN, USA). Cytokines were assayed using a premixed Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead Panel (EMD Millipore Corp., St. Charles, MO, USA) and measured using a Luminex 200 instrument (Luminex, Austin, TX, USA). All plasma biomarkers were analyzed by the University of Michigan Cancer Center Immunological Monitoring Core (Ann Arbor, MI, USA). Both methods and detection limits have been described in detail elsewhere [22 (link)]. As with phthalate metabolites, inflammation biomarker measurements below the LOD were replaced by the LOD divided by the square root of 2 [23 ].
+ Open protocol
+ Expand
5

Inflammatory Biomarkers in Plasma Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 120 subjects,
plasma samples (N = 215 total) from visits 1 (N = 119) and 3 (N = 96) were available
for measurement of C-reactive protein (CRP) as well as 4 cytokines
as biomarkers of inflammation. These measurements were performed by
the University of Michigan Cancer Center Immunological Monitoring
Core (Ann Arbor, MI). CRP was measured using a DuoSet enzyme-linked
immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN), and
cytokines, including interleukin (IL)-1β, IL-6, IL-10, and tumor
necrosis factor (TNF)-α, were measured using a Milliplex MAP
High Sensitivity Human Cytokine Magnetic Bead Panel (EMD Millipore
Corp., St. Charles, MO) with a Luminex L200 instrument (Luminex, Austin,
TX). Cytokines were analyzed in duplicate and an arithmetic average
of the two measurements was created for data analysis. CRP or cytokine
levels below the LOD were replaced by the LOD divided by the square
root of 2.19
+ Open protocol
+ Expand
6

Biomarkers of Inflammation in Cohort

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the time of the present analysis, a total of 187 blood samples from visits 1 (n=103) and 3 (n=84) were available from a subset of 105 participants for measurement of inflammation biomarkers. These samples were processed for the collection of plasma, which was divided into aliquots, frozen at −80°C, and shipped overnight on dry ice to the University of Michigan. C-reactive protein (CRP) and the cytokines interleukin (IL)-1β, IL-6, IL-10, and tumor necrosis factor (TNF)-α were measured by the University of Michigan Cancer Center Immunological Monitoring Core (Ann Arbor, MI). CRP was measured using a DuoSet enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN), and cytokines were measured using a Milliplex MAP High Sensitivity Human Cytokine Magnetic Bead Panel (EMD Millipore Corp., St. Charles, MO) with a Luminex L200 instrument (Luminex, Austin, TX). Cytokines were analyzed in duplicate and an arithmetic average of the two measurements was created for data analysis. The inter-assay coefficients of variation for the CRP and cytokine assays range from 5 to 19%. CRP and cytokine levels below the LOD were replaced by the LOD/√2 (Hornung and Reed, 1990 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!